Scancell Holdings plc

AIM:SCLP Stock Report

Market Cap: UK£101.7m

Scancell Holdings Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Phillip L’Huillier

Chief executive officer

UK£392.0k

Total compensation

CEO salary percentage40.63%
CEO tenure1yr
CEO ownershipn/a
Management average tenure1.8yrs
Board average tenure4yrs

Recent management updates

Recent updates

Is Scancell Holdings (LON:SCLP) A Risky Investment?

Oct 29
Is Scancell Holdings (LON:SCLP) A Risky Investment?

Is Scancell Holdings (LON:SCLP) A Risky Investment?

Feb 10
Is Scancell Holdings (LON:SCLP) A Risky Investment?

Here's What Scancell Holdings plc's (LON:SCLP) Shareholder Ownership Structure Looks Like

Dec 28
Here's What Scancell Holdings plc's (LON:SCLP) Shareholder Ownership Structure Looks Like

CEO Compensation Analysis

How has Phillip L’Huillier's remuneration changed compared to Scancell Holdings's earnings?
DateTotal CompensationSalaryCompany Earnings
Apr 30 2025UK£392kUK£159k

-UK£12m

Compensation vs Market: Phillip's total compensation ($USD515.43K) is about average for companies of similar size in the UK market ($USD399.73K).

Compensation vs Earnings: Insufficient data to compare Phillip's compensation with company performance.


CEO

Phillip L’Huillier (63 yo)

1yr
Tenure
UK£391,966
Compensation

Dr. Phillip John L’Huillier, PhD, MBA, is CEO & Director of Scancell Holdings plc from November 18, 2024. He served as Chief Executive Officer at CatalYm GmbH since May 17, 2021. He served as the Managing...


Leadership Team

NamePositionTenureCompensationOwnership
Phillip L’Huillier
CEO & Director1yrUK£391.97kno data
Lindy Durrant
Chief Scientific Officerno dataUK£386.80k0.20%
£ 202.8k
Sathijeevan Nirmalananthan
CFO, Company Secretary & Director2.3yrsUK£267.75k0.018%
£ 18.7k
Samantha Paston
Head of Translational Research6.8yrsno datano data
Mandeep Sehmi
Head of Business Development2.2yrsno datano data
Callum Scotthasbeen
Senior Vice President of Development1.8yrsno datano data
Alex Hayward
Head of Finance1.8yrsno datano data
Nermeen Varawalla
Chief Medical Officer1.3yrsno datano data
Shamim Stokes
Head of Programme Managementless than a yearno datano data
Philip Angell-Manning
Head of CMCless than a yearno datano data
1.8yrs
Average Tenure
63yo
Average Age

Experienced Management: SCLP's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Phillip L’Huillier
CEO & Director1yrUK£391.97kno data
Lindy Durrant
Chief Scientific Officer17.6yrsUK£386.80k0.20%
£ 202.8k
Sathijeevan Nirmalananthan
CFO, Company Secretary & Director1.7yrsUK£267.75k0.018%
£ 18.7k
Florian Nicolas Reinaud
Non-Executive Director1.3yrsno datano data
Ursula Ney
Independent Non-Executive Director6.1yrsUK£40.00kno data
Jean-Michel Yves Cossery
Non-Executive Chairman2.8yrsUK£100.00k0.044%
£ 44.5k
Martin Diggle
Non-Executive Director6.4yrsno datano data
Susan Clement-Davies
Independent Non-Executive Deputy Chair5.2yrsUK£55.00kno data
4.0yrs
Average Tenure
63yo
Average Age

Experienced Board: SCLP's board of directors are considered experienced (4 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/18 02:22
End of Day Share Price 2025/11/18 00:00
Earnings2025/04/30
Annual Earnings2025/04/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Scancell Holdings plc is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Julie SimmondsPanmure Liberum
Julie SimmondsPanmure Liberum
James OrsborneStifel, Equities Research